3.4.21.46: complement factor D
This is an abbreviated version!
For detailed information about complement factor D, go to the full flat file.
Word Map on EC 3.4.21.46
-
3.4.21.46
-
angiogenesis
-
angiogenic
-
vessel
-
metastasis
-
neovascularization
-
hypoxia
-
artery
-
hypoxia-inducible
-
necrosis
-
retinal
-
antiangiogenic
-
umbilical
-
bevacizumab
-
microvessels
-
vein
-
capillary
-
factor-1
-
huvecs
-
vegfr-2
-
collagen
-
vasculature
-
retinopathy
-
eyes
-
ovarian
-
macular
-
tumour
-
tube
-
microvascular
-
mesenchymal
-
anti-vegf
-
lymphatic
-
receptor-2
-
pro-angiogenic
-
bfgf
-
intravitreal
-
progression-free
-
edema
-
choroid
-
metalloproteinase
-
endothelium
-
hypertension
-
sprout
-
matrigel
-
paracrine
-
lymph
-
hif-1alpha
-
mmp-9
-
sunitinib
-
drug development
-
sorafenib
-
vitreous
-
medicine
- 3.4.21.46
- angiogenesis
-
angiogenic
- vessel
- metastasis
- neovascularization
- hypoxia
- artery
-
hypoxia-inducible
- necrosis
- retinal
-
antiangiogenic
-
umbilical
-
bevacizumab
-
microvessels
- vein
- capillary
- factor-1
- huvecs
- vegfr-2
- collagen
- vasculature
- retinopathy
- eyes
- ovarian
-
macular
- tumour
- tube
-
microvascular
- mesenchymal
-
anti-vegf
- lymphatic
- receptor-2
-
pro-angiogenic
- bfgf
-
intravitreal
-
progression-free
- edema
- choroid
- metalloproteinase
- endothelium
- hypertension
-
sprout
- matrigel
-
paracrine
- lymph
- hif-1alpha
- mmp-9
- sunitinib
- drug development
- sorafenib
- vitreous
- medicine
Reaction
selective cleavage of Arg-/-Lys bond in complement factor B when in complex with complement subcomponent C3b or with cobra venom factor =
Synonyms
28 kDa protein, adipocyte, Adipsin, alternative complement pathway component Factor D, C3 convertase activator, C3 proactivator convertase, CFD, complement factor D/adipsin and kallikrein-like serine protease, convertase, C3 proactivator, Df, Df protein, endogenous vascular elastase, esterase, properdin factor D, factor D, factor D (complement), fD, PDGF-D, platelet-derived growth factor D, PoDAK, vascular endothelial growth factor, vascular endothelial growth factor D, VEGF-D
ECTree
Advanced search results
Activating Compound
Activating Compound on EC 3.4.21.46 - complement factor D
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
complement factor B
the enzyme factor D is activated by its substrate factor B through interactions outside the active site. The substrate-binding, or exosite, region displays a well defined and rigid conformation
-
-
A direct repeat element located in the proximal human vegf-D gene promoter, consisting of a consensus half-site (AGGTCA) at -125/-119 and a degenerated direct repeat half-site (ATGTTA) at -99/-94 is sufficient and necessary for vegf-D transcription. The vegf-D direct repeat element is bound and activated by the orphan receptors hepatocyte nuclear factor 4A and chicken ovalbumin upstream promoter transcription factor 1 and 2 as well as transcriptional coactivators glucocorticoid receptor interacting protein 1 and cyclic AMP-responsive element binding protein-binding protein to drive vegf-D gene transcription. Histone deacetylase inhibition by trichostatin A leads to accumulation of acetylated histones H3/H4 at the vegf-D promoter, up-regulation of vegf-D mRNA levels, and transactivation of vegf-D promoter reporter gene constructs in cancer cell lines
-
additional information
-
adenovirus-mediated expression of VEGF-D is significantly higher than that of baculovirus
-